Xeprila Trademark Details

Xeprila was registered on Tuesday, December 23, 2003 and is currently owned by Sanofi-Aventis under the registration number 2796500 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 13 years ago on Saturday, July 31, 2010, according to the United State Patent & Trademark Office
Word Mark Xeprila
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Sanofi-Aventis of Allen, TX

View all trademarks for Sanofi-Aventis
Other Trademarks for Sanofi-Aventis

Previous Owners

Sanofi-Synthelabo of Allen, TX

View all trademarks for Sanofi-Synthelabo
Other Trademarks for Sanofi-Synthelabo
Serial Number 76059023
Registration Number 2796500
Status Date Saturday, July 31, 2010
Filing Date Saturday, July 31, 2010
Registration Date Tuesday, December 23, 2003
Attorney Mark I. Peroff
Domestic Representative Trademark & Patent Counselors of America, P.C.

Correspondent

Mark I. Peroff
Kirkpatrick & Lockhart Nicholson Graham
599 Lexington Avenue
New York NY 10022-6030

Case File Statements

Goods & Services Pharmaceutical Preparations, Namely for Preventing or Treating Central Nervous System Disturbances

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Saturday, July 31, 2010
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.